Replacing performance status with a simple patient-reported outcome in palliative radiotherapy prognostic modelling

Glare P. A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ. 2003 Jul 24;327(7408):195–0. Chow, 2005, Accuracy of survival prediction by palliative radiation oncologists, Int J Radiat Oncol Biol Phys, 61, 870, 10.1016/j.ijrobp.2004.07.697 Gripp, 2010, Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: reality or myth?, Cancer, 116, 3251, 10.1002/cncr.25112 Tseng, 2013, How radiation oncologists evaluate and incorporate life expectancy estimates into the treatment of palliative cancer patients: a survey-based study, Int J Radiat Oncol Biol Phys, 87, 471, 10.1016/j.ijrobp.2013.06.2046 Weeks, 1998, Relationship Between Cancer Patients’ Predictions of Prognosis and Their Treatment Preferences, JAMA, 279, 1709, 10.1001/jama.279.21.1709 Chow, 2008, Predictive model for survival in patients with advanced cancer, J Clin Oncol, 26, 5863, 10.1200/JCO.2008.17.1363 Dosani, 2018, The TEACHH model to predict life expectancy in patients presenting for palliative spine radiotherapy: external validation and comparison with alternate models, Support Care Cancer, 26, 2217, 10.1007/s00520-018-4064-x Westhoff, 2014, An Easy Tool to Predict Survival in Patients Receiving Radiation Therapy for Painful Bone Metastases, Int J Radiat Oncol, 90, 739, 10.1016/j.ijrobp.2014.07.051 Bollen, 2014, Prognostic factors associated with survival in patients with symptomatic spinal bone metastases: a retrospective cohort study of 1 043 patients, Neuro-Oncol, 16, 991, 10.1093/neuonc/not318 Chow, 2016, Inter-rater reliability in performance status assessment among health care professionals: a systematic review. Ann, Palliat Med, 5, 83, 10.21037/apm.2016.03.02 May, 2012, PS score discordance and why it matters, Lung Cancer, 75, S18, 10.1016/S0169-5002(12)70055-7 Pajouheshnia, 2019, How variation in predictor measurement affects the discriminative ability and transportability of a prediction model, J Clin Epidemiol, 1, 136, 10.1016/j.jclinepi.2018.09.001 Park, 2006, EuroQol and survival prediction in terminal cancer patients: a multicenter prospective study in hospice-palliative care units, Support Care Cancer, 14, 329, 10.1007/s00520-005-0889-1 Diouf, 2014, Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study, Health Qual Life Outcomes, 12, 69, 10.1186/1477-7525-12-69 Clarke, 2009, Using the EQ-5D Index Score as a Predictor of Outcomes in Patients With Type 2 Diabetes, Med Care, 47, 61, 10.1097/MLR.0b013e3181844855 Mathews, 2007, EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults under care, Health Qual Life Outcomes, 5, 5, 10.1186/1477-7525-5-5 ECOG Performance Status [Internet]. ECOG-ACRIN. [cited 2020 Aug 10]. Available from: https://ecog-acrin.org/resources/ecog-performance-status. EuroQol Group. EQ-5D-3L [Internet]. [cited 2018 Oct 4]. Available from: https://euroqol.org/eq-5d-instruments/eq-5d-3l-about/. Steenland, 1999, The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study, Radiother Oncol, 52, 101, 10.1016/S0167-8140(99)00110-3 van den Hout, 2003, Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial, J Natl Cancer Inst, 95, 222, 10.1093/jnci/95.3.222 van der Linden, 2004, Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment, Int J Radiat Oncol, 59, 528, 10.1016/j.ijrobp.2003.10.006 Royston, 2004, A new measure of prognostic separation in survival data, Stat Med, 23, 723, 10.1002/sim.1621 Altman, 2000, What do we mean by validating a prognostic model?, Stat Med, 19, 453, 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5 Riley, 2019, 373 p. Buchholz, 2018, A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D, PharmacoEconomics, 36, 645, 10.1007/s40273-018-0642-5 Groenvold, 2006, The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care, Eur J Cancer, 42, 55, 10.1016/j.ejca.2005.06.022 Hussain, 2016, Missing data in randomized controlled trials testing palliative interventions pose a significant risk of bias and loss of power: a systematic review and meta-analyses, J Clin Epidemiol, 74, 57, 10.1016/j.jclinepi.2015.12.003 Rolstad, 2011, Response Burden and Questionnaire Length: Is Shorter Better?, A Review and Meta-analysis Value Health, 14, 1101, 10.1016/j.jval.2011.06.003 Husson O, de Rooij BH, Kieffer JM, Oerlemans S, Mols F, Aaronson NK, et al. Independent prognostic value of the EORTC QLQ-C30 summary score on all-cause mortality: Results from the population-based PROFILES registry. J Clin Oncol. 2018 May 20;36(15_suppl):10070–10070. Hounsome, 2011, EQ-5D as a quality of life measure in people with dementia and their carers: evidence and key issues, Value Health J Int Soc Pharmacoeconomics Outcomes Res, 14, 390, 10.1016/j.jval.2010.08.002 Pickard, 2009, Proxy Assessment of Health-Related Quality of Life in African American and White Respondents With Prostate Cancer, Med Care, 47, 176, 10.1097/MLR.0b013e31818475f4